Skip to main content

LivaNova

LivaNova plc is a global medical technology company that designs, develops, and distributes cardiovascular and neuromodulation therapy solutions. The company operates through two primary business segments: Neuromodulation, featuring implantable vagus nerve stimulation systems for drug-resistant epilepsy and depression, and Cardiovascular, producing advanced cardiopulmonary bypass systems and heart-lung machine equipment. Its products are deployed in surgical operating rooms and hospital clinics worldwide to treat complex neurological and heart conditions. Revenue is derived directly from the sale of medical devices, surgical equipment, and proprietary implantable accessories to healthcare providers. LivaNova holds a leading global market position in neuromodulation therapy for epilepsy. The company is headquartered in London, United Kingdom, and its ordinary shares trade on the Nasdaq Global Select Market.

8 of the funds FundTelligence covers report a position in LivaNova.

Legal name
LivaNova Plc
Sector
Health Care
Country
United Kingdom
Funds holding it
8

Funds holding LivaNova

Loading...